The Washington Post does an exclusive interview with Aperiomics CEO Crystal Icenhour.

“I was dubious when Crystal Icenhour approached me to write about her medical testing company.

It sounded too much like Theranos, the discredited start-up that claimed to have medical technology that revolutionized blood testing by using minuscule samples.

Theranos ceased operations last year, and its founder, Elizabeth Holmes, the self-made billionaire and “next Steve Jobs,” faces federal fraud charges. Forbes magazine reduced its estimate of her net worth from $4.5 billion to zero.

Icenhour is no billionaire, but the gritty Texan — she cleaned floors in her family’s truck-repair shop — is an entrepreneur with a doctorate in molecular medicine from the University of Cincinnati Medical School….”

Read the full story at:

Washington Post